Based on current knowledge, treatment aimed at reducing oxidative stress should decrease ADMA levels [6], and it is logical to suggest that such a therapy might help to preserve RRF in HD patients. In our opinion, it is worth to check an ability of antioxidant therapy to produce a favorable effect on RRF. One preliminary study on effect of antioxidant Vitamin E showed a small beneficial effect on ADMA in chronic kidney disease [7].